期刊文献+

抗人CD80双价抗体的构建、表达及生物学功能初步研究 被引量:2

Construction,expression and biological function assay of anti-human CD80 bivalent dimer
原文传递
导出
摘要 构建及表达抗人CD80双价抗体(dimeric antibody fragment,diabody),并初步研究其生物学功能。PCR法获得轻重链可变区基因,构建表达载体pIRES2-EGFP/diabody。将pIRES2-EGFP/diabody转染中华仓鼠卵巢细胞(CHO),G418加压,筛选稳定高表达细胞株,扩大培养并收集上清,经镍柱纯化,并经变性及非变性SDS-PAGE电泳对抗体分子的双体性进行鉴定。采用免疫荧光及流式细胞术(FCM)分析抗体与细胞膜型CD80分子的结合活性及与鼠源性亲本抗体4E5的竞争抑制效应;MTT法分析该抗体对天然高表达CD80的Raji细胞体外增殖的影响。结果:成功构建抗人CD80-diabody表达载体并含有编码信号肽和Gly4Ser连接肽的序列。获得了稳定分泌双价抗体的细胞株(命名为SA-Ⅲ),培养上清中纯化抗体的得率为50 mg/L,PAGE结果显示其为一个二聚体,Mr约为53 000(抗人CD80-ScFv Mr约为27 000)。抗CD80-diabody与L929-CD80、Raji及Daudi的阳性结合率分别为96.5%、98.1%及93.0%;该抗体对鼠源亲本抗体4E5与抗原结合的抑制率为97.11%,对Raji细胞体外增殖的抑制率达31.27%。与单链抗体相比,亲和活性明显提高。成功建立了抗CD80-diabody CHO细胞的表达株,其分泌的抗体具有良好的生物学活性。 To construct and express anti-human CD80 bivalent dimmer(diabody) and to study its biological functions,VH and VL genes were cloned by PCR,and then subcloned into the eukaryotic expression vector pIRES2-EGFP to construct recombinant pIRES2-EGFP/diabody.Chinese hamster ovary(CHO) cells was transfected by this recombinant plasmid through liposome-mediated methods and selected by G418.The anti-human CD80-diabody was purified from culture supernatants by Ni catridges.Reducing and non-reducing SDS-PAGE was used to analyze its bivalent property.The identification of diabody to membrane CD80 and competitive inhibition effect against the parent antibody 4E5 were performed via immunofluorescence and FCM.Meanwhile,the effect of anti-human CD80-diabody on the proliferation of Raji cells expressing CD80 highly and naturally was detected by MTT method.By using these methods,the expression vector for pIRES2-EGFP/diabody against CD80 was constructed successfully.This vector concluded a sequence of 798 bp in length,part of which encoded signal peptide and Gly4Ser linker peptide.One cell line stably secreting diabody was obtained and named as SA-Ⅲ.Appromately,50 milligram of CD80-diabody could be purified from one liter of culture supernatant.The molecular weight(Mr) of this dimer was about 53 000,while Mr of ScFv was about 27 000.The positive binding rates of anti-human CD80-diabody with L929-CD80,Raji and Daudi cells were 96.5%,98.1% and 93% respectively.This diaboby could inhibit not only the combination of the parent antibody 4E5 with CD80 antigen in an inhibition rate of 97.11%,but also the in vitro proliferation of Raji cells with a corresponding rate of 31.27%.Conclusively,a CHO cell line secreting anti-human CD80-diabody was generated and its secreted diabody shows good biological function.
出处 《现代免疫学》 CAS CSCD 北大核心 2011年第3期192-196,共5页 Current Immunology
基金 国家科技部科技重大专项资助项目(2009ZX09103-705)
关键词 CD80 双价抗体 真核表达 CD80 diabody eukaryotic expression
  • 相关文献

参考文献7

  • 1Holliger P, Prospero T, Winter G. "Diabodies": small biva lent and bispecific antibody fragments[J]. Proc Natl Acad Sci USA, 1993,90:6444- 6448.
  • 2Wu AM, Chen W, Raubitschek A, etal. Tumor localization of anti-CEA single chain Fvs: improved targeting by non co-valent dimers[J]. Immunotechnology 1996,2 :21-36.
  • 3Tsukada N, Aoki S, Maruyama S, et al. The heterogeneous expression of CD80, CD86 and other adhesion molecules on leukemia and lymphoma cells and their induction by interfer- on[J]. Exp Clin Cancer Res, 1997,16:171-176.
  • 4Suvas S, Singh V, Sahdev S, etal. Distinct role of CD80 and CD86 in the regulation of the activation of B cell and B cell lymphoma[J]. J Biol Chem, 2002,277 : 7766-7775.
  • 5王艳茹,马泓冰,陈永井,朱华亭,刘玉华,杜阳阳,孙杰,陈明心,邱玉华.CD80人-鼠嵌合抗体对B淋巴瘤细胞株Raji与Daudi的生长抑制及杀伤作用[J].细胞与分子免疫学杂志,2009,25(7):615-618. 被引量:9
  • 6梁文飚,邱玉华,孙静,李大为,施勤,陈永井,郁建锋,于葛华,张学光.B7-1 mAb对B系淋巴瘤Raji细胞的生长抑制和凋亡诱导作用[J].上海免疫学杂志,2003,23(2):87-90. 被引量:3
  • 7Peter J, Hudson A, lexander A, et al. High avidity scFv muhimers: diabodies and triabodies[J]. J Immunol Meth- ods, 1999,231:177-189.

二级参考文献5

共引文献10

同被引文献15

  • 1张晶,谢幸,叶大风.黏附分子与肿瘤免疫逃逸[J].实用肿瘤杂志,2004,19(5):449-452. 被引量:18
  • 2李慧,任秀宝,郝希山.B7家族的新成员—B7-H1、B7-H2、B7-H3、B7-DC[J].国外医学(免疫学分册),2005,28(1):41-43. 被引量:5
  • 3路静,赵军,宋谦,崔自由,赵国强,黄幼田,杨洪艳,赵继敏,董子明.人B7-2瘤苗与DC瘤苗体外联合诱导抗食管癌的作用[J].世界华人消化杂志,2005,13(12):1382-1385. 被引量:5
  • 4罗毅平,陈慎仁,杨伟.CD80和CD86在食管癌组织中的表达[J].海南医学院学报,2006,12(3):204-206. 被引量:3
  • 5Gabriel L Sica,In-Hak Choi,Gefeng Zhu,Koji Tamada,Sheng-Dian Wang,Hideto Tamura,Andrei I Chapoval,Dallas B Flies,Jürgen Bajorath,Lieping Chen.B7-H4, a Molecule of the B7 Family, Negatively Regulates T Cell Immunity[J]Immunity,2003(6).
  • 6Durbaka V.R Prasad,Sabrina Richards,Xoi Muoi Mai,Chen Dong.B7S1, a Novel B7 Family Member that Negatively Regulates T Cell Activation[J]Immunity,2003(6).
  • 7Xingqian Zhang,Wenhan Mei,Leilei Zhang,Hai Yu,Xiaoping Zhao,Xianqun Fan,Guanxiang Qian,Shengfang Ge.Co-expression of P1A35-43/β2m fusion protein and co-stimulatory moleculeCD80 elicits effective anti-tumor immunity in the P815 mouse mastocytoma tumormodel[J].Oncology Reports.2009(5)
  • 8Hideaki Shimada,Tooru Shiratori,Shinichi Okazumi,Hisahiro Matsubara,Yoshihiro Nabeya,Kiyohiko Shuto,Yasunori Akutsu,Hideki Hayashi,Kaichi Isono,Takenori Ochiai.Have Surgical Outcomes of Pathologic T4 Esophageal Squamous Cell Carcinoma Really Improved? Analysis of 268 Cases During 45 Years of Experience[J].Journal of the American College of Surgeons.2008(1)
  • 9Christian Blank,Andreas Mackensen.Contribution of the PD-L1/PD-1 pathway to T-cell exhaustion: an update on implications for chronic infections and tumor evasion[J].Cancer Immunology Immunotherapy.2007(5)
  • 10王甲甲,李官成.基因工程双价抗体在肿瘤中的研究进展[J].国际病理科学与临床杂志,2008,28(6):508-511. 被引量:4

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部